ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of life"

  • Abstract Number: 0433 • ACR Convergence 2024

    Male Perspective on Reproductive Health in Rheumatology Patients: A Cross-sectional Study

    Eleonora Giacobbe1, Maria Chiara Gerardi2, Clizia Gagliardi2, Sara Benedetti2, Giuseppina Di Raimondo2, Assunta Ascione3, Monica Barichello2, Nicola Ughi4, Antonella Adinolfi2, Laura Belloli2, Cinzia Casu2, Maria Di Cicco2, Davide antonio Filippini2, Matteo Longhi2, Bianca Lucia Palermo2, Martina Schettino2, Giulia Segatto2, Elisa Verduci2 and Oscar Massimiliano Epis2, 1Niguarda Hospital, Milan, Milan, Lombardia, Italy, 2Niguarda Hospital, Milan, Milan, Italy, 3Niguarda Hospital, Milan, Milan, 4Niguarda Hospital, Milan, Mila, Italy

    Background/Purpose: As reproductive health is gathering attention in rheumatology and all medical fields, the male perspective on the matter is often overlooked as not directly…
  • Abstract Number: 1086 • ACR Convergence 2024

    Risk Factors Associated with Loss to Follow-up in a Prospective Gout Cohort

    HYUNSUE DO1, Min Jung Kim2, Kichul Shin3 and Ki Won Moon4, 1Kangwon national university hospital, Seoul, South Korea, 2Seoul Metropolitan Government Boramae Medical center, Dongjak-gu, Seoul, South Korea, 3Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, South Korea, 4Kangwon National University hospital, Chuncheon-si, Republic of Korea

    Background/Purpose: Gout, a prevalent form of inflammatory arthritis, is generally considered to be easy to manage with urate lowering agent. However, many patients with gout…
  • Abstract Number: 1913 • ACR Convergence 2024

    Health Literacy and Disease, Clinical, Functional and Management Outcomes in Inflammatory Arthritis: A Systematic Literature Review

    Mrinalini Dey1, Shyam Budhathoki2, Sofia Ramiro3, Kaleb Michaud4, Helen Elwell5, Sam Norton6, Maya H. Buch7, Andrew Cope1, Richard Osborne8, James Galloway9 and Elena Nikiphorou1, 1King's College London, London, United Kingdom, 2Imperial College London, London, United Kingdom, 3Leiden University Medical Center, Bunde, Netherlands, 4University of Nebraska Medical Center, Omaha, NE, 5British Medical Association, London, United Kingdom, 6King's College London, London, England, United Kingdom, 7Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom, 8Swinburne University of Technology, Swinburne, Australia, 9Centre for Rheumatic Diseases, King's College London, London, United Kingdom

    Background/Purpose: Health literacy (HL) is a key social determinant of health in inflammatory arthritis (IA), including rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, as it…
  • Abstract Number: 2461 • ACR Convergence 2024

    Prevalence and Impact of Peripheral Neuropathy in SSc: A Frequent and Disabling Manifestation in SSc, and a Potential Surrogate Marker for Autonomic Neuropathy

    Begonya Alcacer-Pitarch1, marco di battista2, Anthony C. Redmond3, Anne-Maree Keenan4, Stefano Di Donato5, Francesco Del Galdo3 and Maya H. Buch6, 1Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, 2Rheumatology Unit, University of Pisa, Pisa., Pisa., Italy, 3University of Leeds, Leeds, United Kingdom, 4School of Healthcare, university of leeds, leeds, United Kingdom, 5Leeds Institute of Rheumatic and Musculoskeletal Medicine, Chapel Allerton Hospital, Leeds, UK, Leeds, United Kingdom, 6Division of Musculoskeletal & Dermatological Sciences, University of Manchester, and NIHR Manchester Biomedical Research Centre, Manchester, United Kingdom

    Background/Purpose: SSc patients have high disability and low quality of life (QoL), driven partially by poor physical function (PF), Gastro Intestinal (GI) problems, digital ulcers…
  • Abstract Number: 0449 • ACR Convergence 2024

    Evaluating Premenstrual Dysphoric Disorder in Women with Rheumatoid Arthritis and Healthy Female Subjects

    Ana Cecilia Bardan-Inchaustegui1, Iris Jazmín Colunga Pedraza2, Rosa Icela Arvizu-Rivera2, Gisela Garcia-Arellano3, Griselda Serna-Peña4, Maria F. Elizondo-Benitez5, Aleydis Gonzalez Melendez2, Fernanda Massiel Garcia6 and Dionicio Galarza-Delgado7, 1Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 3Hospital Universitario \"Dr. José Eleuterio González\", Monterrey, Nuevo León, Mexico, 4Hospital Universitario "Dr. José Eleuterio González", UANL, Monterrey, Mexico, 5Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 6Hospital Universitario Dr José Eleuterio González, Monterrey, Nuevo León, Mexico, 7UANL Hospital Universitario, Monterrey, Nuevo León, Mexico

    Background/Purpose: Premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome, is classified as a psychiatric disorder characterized by moderate to severe physical, affective, or…
  • Abstract Number: 1199 • ACR Convergence 2024

    Diclofenac Sodium 1% Gel Improves Physical Function in the Performance of Important Activities of Daily Living in Patients with Hand or Knee Osteoarthritis

    Karin Nicholson, Edwin Sanchez, Nadine Maybaum and Richard Petruschke, Haleon, Warren, NJ

    Background/Purpose: Osteoarthritis (OA) is the most common form of arthritis, with hand and knee being among the most afflicted joints.  Symptoms of OA include joint…
  • Abstract Number: 1939 • ACR Convergence 2024

    Patient’s Satisfaction with a Telerheumatology Program in a Remote Rural Area of Northern Pakistan

    Tayyeba Khursheed1, Usman A. Raza2, Uzma Rasheed1 and Wajahat Aziz1, 1Pakistan Institute of Medical Sciences, Islamabad, Islamabad, Pakistan, 2ClaritasRx, South San Fransisco, CA

    Background/Purpose: Telerheumatology has emerged as a promising tool for improving access to rheumatology services globally. Health delivery in remote rural areas is particularly challenging. Telerheumatology…
  • Abstract Number: 2476 • ACR Convergence 2024

    The Impact of Systemic Sclerosis Manifestations on Survival and Humanistic Burden: A Targeted Literature Review

    vanessa smith1, Zoe Marjenberg2 and Elizabeth Volkmann3, 1Ghent University Hospital, Gent, Belgium, 2Maverex Ltd, North Shields, United Kingdom, 3University of California, Department of Medicine, Los Angeles, CA, USA, Los Angeles

    Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease with multiple disease manifestations, including cutaneous fibrosis, musculoskeletal inflammation, Raynaud phenomenon, calcinosis and digital ulceration. Internal…
  • Abstract Number: 0518 • ACR Convergence 2024

    Sustained Patient Meaningful Outcomes of Pain and Fatigue Relief and Improved Physical Functioning with Filgotinib in Rheumatoid Arthritis: A Post Hoc Analysis

    Rieke Alten1, Bruno Fautrel2, Philip G Conaghan3, Dick de Vries4, Margaux Faes5, Mercedes Piovesan6, Katrien Van Beneden7, Chris Watson8, Angelique E.A.M. Weel-Koenders9, Eugen Feist10 and Kurt de Vlam11, 1Department of Internal Medicine and Rheumatology, Schlosspark Klinik, University Medicine Berlin, Berlin, Germany, 2INSERM, UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and Sorbonne University – Assistance Publique-Hôpitaux de Paris, Département de Rhumatologie, Hôpital Pitié-Salpêtrière, Paris, Ile-de-France, France, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 4Clinical Development, Galapagos BV, Leiden, Netherlands, 5Biostatistics, Galapagos NV, Mechelen, Belgium, 6Medical Affairs, Galapagos Biopharma Spain SLU, Madrid, Spain, 7Medical Affairs, Galapagos NV, Mechelen, Belgium, 8Medical Affairs, Galapagos Biotech Ltd, Cambridge, United Kingdom, 9Erasmus School of Health Policy and Management, Erasmus University Rotterdam, and Department of Rheumatology and Clinical Immunology, Maasstad Hospital, Rotterdam, Netherlands, 10Department of Rheumatology, Helios Clinic Vogelsang-Gommern, cooperation partner of the Otto von Guericke University Magdeburg, Gommern, Germany, 11Department of Rheumatology, UZ Leuven, and Department of Development and Regeneration, Skeletal Biology and Engineering Research Center, KU Leuven, Leuven, Belgium

    Background/Purpose: Quality of life for patients with RA can be severely impacted by pain, fatigue and impaired physical functioning.1 Filgotinib (FIL) has demonstrated early onset…
  • Abstract Number: 1221 • ACR Convergence 2024

    Efficacy of Immersive Virtual Reality-based Biofeedback on Chronic Pain and Daily Life Impact in Fibromyalgia: A Pilot Randomized Controlled Trial

    Luca Chittaro1, Simone Longhino2, Marta Serafini1, Sofia Cacioppo2 and Luca Quartuccio3, 1Human-Computer Interaction Lab, Department of Mathematics, Computer Science and Physics, University of Udine, Udine, Italy, 2Division of Rheumatology, Department of Medicine, University of Udine, UDine, Italy, 3Division of Rheumatology, Department of Medicine (DMED), University of Udine, Udine, Italy, Udine, Italy

    Background/Purpose: Fibromyalgia (FM) affects 2% of the global population, causing chronic musculoskeletal pain, fatigue, sleep and mood disorders, significantly impacting quality of life. Although many…
  • Abstract Number: 2015 • ACR Convergence 2024

    Health-Related Quality of Life in Patients with Gout Receiving Treat-to-Target Urate-Lowering Therapy

    Austin Barry1, Harlan Sayles1, Lindsay Helget1, Maria Androsenko2, Hongsheng Wu3, Kaleb Michaud1, Bridget Kramer1, Jeff Newcomb1, Mary Brophy3, Anne Davis-Karim4, Bryant England1, Ryan Ferguson3, Michael Pillinger5, Tuhina Neogi6, Paul Palevsky7, James O'Dell1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2Department of VA, Newton, MA, 3Veterans Affairs, Boston, MA, 4Veterans Affairs, Albuquerque, NM, 5New York University Grossman School of Medicine, New York,, NY, 6Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 7University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Gout is associated with decreased health-related quality of life (HRQoL). The ACR endorses treat-to-target (TtT) urate-lowering therapy (ULT) for gout with a serum urate…
  • Abstract Number: PP01 • ACR Convergence 2024

    An OCEAN of Change: The Impact of an RA Diagnosis on My Big Five Personality Traits

    Laura Sambursky1 and Lauren Sambursky2, 1Patient, Sarasota, FL, 2Northeastern University, Boston, MA

    Background/Purpose: Until age 32, I was a healthy, confident, extraverted, and creative person. I moved hundreds of miles away for college and then earned a…
  • Abstract Number: 0569 • ACR Convergence 2024

    The Longitudinal Association Between Disease Activity, Function and Health-Related Quality of Life in Axial Spondyloarthritis: Results from the DESIR Cohort

    Augusta Ortolan1, Desiree van der Heijde2, Laure Gossec3 and Sofia Ramiro4, 1Policlinico Universitario Agostino Gemelli IRCSS, Rome, Lazio, Italy, 2Department of Rheumatology, Leiden University Medical Center, Meerssen, Netherlands, 3Sorbonne Université, Paris, France, 4Leiden University Medical Center, Bunde, Netherlands

    Background/Purpose: Health-related quality of life (HRQoL) in axSpA is considered an overarching outcome, with other disease outcomes contributing to it [1]. To validate a previously…
  • Abstract Number: 0446 • ACR Convergence 2023

    Review of Rheumatoid Arthritis Treatment Landscape During the COVID-19 Pandemic

    Rachel Connolly1, MamTing Thoo2, Elizabeth Baynton3 and Denise Baldock3, 1Ipsos, New York, NY, 2Ipsos SDN BHD, Kuala Lumpur, Malaysia, 3Ipsos MORI UK, London, United Kingdom

    Background/Purpose: During the COVID-19 pandemic, guidelines were amended with respect to the prescribing of biologic/tsDMARD usage to treat rheumatoid arthritis (RA). In addition, regulatory reviews…
  • Abstract Number: 1039 • ACR Convergence 2023

    Cross-Sectional Associations of Ultrasound Features with Symptom Outcomes at the Knee: A Community-based Study

    Katherine Yates1, Carolina Alvarez2, Todd Schwartz3, Serena Savage-Guin4, Jordan Renner4, Catherine Bakewell5, Minna Kohler6, Janice Lin7, Jonathan Samuels8 and Amanda Nelson4, 1University of North Carolina Medical Center, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Miami, FL, 3University of North Carolina-Chapel Hill, Chapel Hill, NC, 4University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Intermountain Healthcare, Salt Lake City, UT, 6Massachusetts General Hospital, Harvard Medical School, Boston, MA, 7Stanford University, Palo Alto, CA, 8NYU Langone, Rye Brook, NY

    Background/Purpose: Ultrasound (US) allows for visualization of many features of knee osteoarthritis (KOA) including osteophytes, meniscal extrusion, synovitis, and articular cartilage damage. Additionally, US is…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 30
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology